Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Kendall Beck"'
Autor:
Elvira Mennillo, Yang Joon Kim, Gyehyun Lee, Iulia Rusu, Ravi K. Patel, Leah C. Dorman, Emily Flynn, Stephanie Li, Jared L. Bain, Christopher Andersen, Arjun Rao, Stanley Tamaki, Jessica Tsui, Alan Shen, Madison L. Lotstein, Maha Rahim, Mohammad Naser, Faviola Bernard-Vazquez, Walter Eckalbar, Soo-jin Cho, Kendall Beck, Najwa El-Nachef, Sara Lewin, Daniel R. Selvig, Jonathan P. Terdiman, Uma Mahadevan, David Y. Oh, Gabriela K. Fragiadakis, Angela Pisco, Alexis J. Combes, Michael G. Kattah
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-19 (2024)
Abstract Ulcerative colitis (UC) is driven by immune and stromal subsets, culminating in epithelial injury. Vedolizumab (VDZ) is an anti-integrin antibody that is effective for treating UC. VDZ is known to inhibit lymphocyte trafficking to the intest
Externí odkaz:
https://doaj.org/article/0ea20593138a4ffda5f1bf392dc9a45e
Autor:
Elvira Mennillo, Yang Joon Kim, Iulia Rusu, Gyehyun Lee, Leah C. Dorman, Faviola Bernard-Vazquez, Jared L. Bain, Ravi Patel, Christopher Andersen, Arjun Rao, Stanley Tamaki, Jessica Tsui, Alan Shen, Mohammad Naser, Walter Eckalbar, Soo-jin Cho, Kendall Beck, Najwa El-Nachef, Sara Lewin, Daniel R Selvig, Jonathan P Terdiman, Uma Mahadevan, David Y. Oh, Gabriela K. Fragiadakis, Angela Pisco, Alexis J. Combes, Michael G. Kattah
Publikováno v:
bioRxiv
Ulcerative colitis (UC) is an inflammatory intestinal disorder driven by mucosal immune and stromal subsets, culminating in epithelial injury. Vedolizumab (VDZ) is an anti-integrin monoclonal antibody that is effective for treating UC. VDZ is thought
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e27186b79baedb645bd0b8ac9f32482
https://europepmc.org/articles/PMC9882264/
https://europepmc.org/articles/PMC9882264/
Autor:
Omar Viramontes, Michael J. Peluso, Peter Chin-Hong, Kwun Wah Wen, Stephanie Conner, Kendall Beck, Jennifer D Claytor, Timothy J. Henrich
Publikováno v:
AIDS. 35:2163-2168
Background Despite the risks of immunosuppression, recommendations regarding screening for HIV infection prior to initiation of biologic therapies targeting common rheumatologic disorders, including inflammatory bowel disease (IBD) and inflammatory a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d5144c1bba6de61e1774fdc0c2b816b
https://doi.org/10.1097/qad.0000000000002985
https://doi.org/10.1097/qad.0000000000002985
Publikováno v:
Gastroenterology. 164:S102
BACKGROUND Tofacitinib is associated with sustained steroid-free remission and improved quality of life in patients with ulcerative colitis (UC), with the lowest effective dose recommended for maintenance therapy. However, there is limited real-world
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bae9695a33e321a963a4ae294adf43e8
https://doi.org/10.1053/j.gastro.2023.03.190
https://doi.org/10.1053/j.gastro.2023.03.190
Publikováno v:
The American Journal of Medicine. 132:1410-1413
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3204658e2986c7001bddfa18c650865
https://doi.org/10.1016/j.amjmed.2019.05.028
https://doi.org/10.1016/j.amjmed.2019.05.028
Publikováno v:
American Journal of Gastroenterology. 116:1107-1109
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cff299d79b26f9ccc045e290c385f6c6
https://doi.org/10.14309/ajg.0000000000001126
https://doi.org/10.14309/ajg.0000000000001126
Autor:
Kole Lynch, Najwa El-Nachef, Susan V. Lynch, Zain Kassam, Martin Zydek, Douglas Fadrosh, Brandon LaMere, Tom Leith, Jonathan P. Terdiman, Kendall Beck, Yvette Piceno, Ma Somsouk, Sarah E. Umetsu, Dana Balitzer, Averil Ma, Sara M. Lewin, Daniel Selvig
Publikováno v:
Digestive Diseases and Sciences. 65:1099-1106
This pilot study assessed the efficacy, safety, and microbiome dynamics of fecal microbiota transplantation (FMT) for patients with chronic pouchitis. A prospective open-label pilot study was performed at an academic center among pouchitis patients u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b5f5ec44f04220cc53741f459ee7da7
https://doi.org/10.1007/s10620-019-05715-2
https://doi.org/10.1007/s10620-019-05715-2
Autor:
David Y. Oh, Ryan M. Gill, Michael G. Kattah, Muhammad B. Hammami, Uma Mahadevan, Kendall Beck, Nikhil R. Thiruvengadam
Publikováno v:
Digestive Diseases and Sciences. 64:685-688
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c11667971dbe5bdb0b35f882246c4e13
https://doi.org/10.1007/s10620-019-05534-5
https://doi.org/10.1007/s10620-019-05534-5
Publikováno v:
Gastroenterology. 162:S-112
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bf281e2161a6269612ea33491786c33
https://doi.org/10.1016/s0016-5085(22)60276-2
https://doi.org/10.1016/s0016-5085(22)60276-2
Publikováno v:
The American journal of gastroenterology. 115(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a9720f5b392a7ceb5da49c280aba295
https://pubmed.ncbi.nlm.nih.gov/32453059
https://pubmed.ncbi.nlm.nih.gov/32453059